Skip to main content

. 1989 Dec 9;299(6713):1433–1434. doi: 10.1136/bmj.299.6713.1433-a

Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide.

C O'Callaghan ¹, A D Milner ¹, A Swarbrick ¹

PMCID: PMC1838282 PMID: 2532940

1433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Beasley C. R., Rafferty P., Holgate S. T. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J (Clin Res Ed) 1987 May 9;294(6581):1197–1198. doi: 10.1136/bmj.294.6581.1197-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Latimer K. M., O'Byrne P. M., Morris M. M., Roberts R., Hargreave F. E. Bronchoconstriction stimulated by airway cooling. Better protection with combined inhalation of terbutaline sulphate and cromolyn sodium than with either alone. Am Rev Respir Dis. 1983 Sep;128(3):440–443. doi: 10.1164/arrd.1983.128.3.440. [DOI] [PubMed] [Google Scholar]
Mann J. S., Howarth P. H., Holgate S. T. Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) 1984 Aug 25;289(6443):469–469. doi: 10.1136/bmj.289.6443.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
O'Callaghan C., Milner A. D., Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986 Dec 20;2(8521-22):1424–1425. doi: 10.1016/s0140-6736(86)92735-2. [DOI] [PubMed] [Google Scholar]
O'Callaghan C., Milner A. D., Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. BMJ. 1989 Jan 21;298(6667):160–161. doi: 10.1136/bmj.298.6667.160. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES